Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Oragenics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(1)(2)(3) | Fee Rate | Amount of Registration Fee | ||||||||||||||||||||||
Fees to Be Paid | Equity | Shares of Common Stock, par value $0.001 per share (3) | 457 | (o) | - | - | $ | 5,000,000 | 0.00015310 | $ | 765.50 | ||||||||||||||||||
Fees to Be Paid | Equity | Common Stock warrants (3)(4) | 457 | (g) | - | - | Included above | - | - | ||||||||||||||||||||
Fees to Be Paid | Equity | Shares of Common Stock issuable upon exercise of Common Stock warrants (3) | 457 | (o) | - | - | Included above | - | - | ||||||||||||||||||||
Fees to Be Paid | Equity | Pre-funded warrants (3)(4) | 457 | (g) | - | - | Included above | - | - | ||||||||||||||||||||
Fees to Be Paid | Equity | Shares of Common Stock issuable upon exercise of pre-funded warrants (3) | 457 | (o) | - | - | Included above | - | - | ||||||||||||||||||||
Fees to Be Paid | Equity | Representative Warrants (4) | 457 | (g) | - | - | - | - | - | ||||||||||||||||||||
Fees to Be Paid | Equity | Shares of Common Stock issuable upon exercise of Representative Warrants (5) | 457 | (o) | - | - | 312,500 | 0.00015310 | $ | 47.84 | |||||||||||||||||||
Total Offering Amounts | $ | 5,312,500 | $ | 813.34 | |||||||||||||||||||||||||
Total Fees Previously Paid | $ | $ | 765.50(6) | ||||||||||||||||||||||||||
Total Fee Offsets | — | — | |||||||||||||||||||||||||||
Net Fee Due | $ | 47.84 |
(1) | Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
(2) | Pursuant to Rule 416 under the Securities Act, the securities registered hereby also include an indeterminate number of additional securities as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations, or other similar transactions. |
(3) | The proposed maximum aggregate offering price of the Units (consisting of Common Stock and Common Stock Warrants) will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Units (consisting of Common Stock and Common Stock Warrants) issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Units (consisting of Common Stock and Common Stock Warrants), and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $5,000,000. |
(4) | No fee pursuant to Rule 457(g) of the Securities Act. |
(5) | The registrant has agreed to issue upon the closing of this offering, warrants to the representative of the placement agent (the “Representative Warrants”) entitling it to purchase up to 5% of the number of shares of common stock and pre-funded warrants sold in this offering. The exercise price of the Representative Warrants is equal to 125% of the public offering price of the securities offered hereby. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act, the proposed maximum aggregate offering price of the Representative Warrants is $312,500 , which is equal to 125% of $250,000 (5% of $5,000,000). |
(6) | Fee previously paid upon the initial filing to the registration statement to which this exhibit is attached. |